April 29, 2020 – Sometimes one of the 340B drug pricing program’s greatest impacts can be seen when patients going through difficult health circumstances receive the financial support they need to focus on what matters most in their lives. That is what happened for Philadelphia resident Cheryl Chupp. When Cheryl was diagnosed with breast cancer in 2015, she knew she needed … [Read more...]
Pandemic Highlights Persistent Disparities in Care
April 22, 2020— The COVID-19 pandemic is the latest public health issue to highlight the persistent gaps among different groups of Americans in accessing needed care and attaining their best possible health outcomes. Amid another sobering reminder of these disparities, 340B hospitals continue to focus their missions on serving the underserved. Early reports during the … [Read more...]
Faces of 340B: Keeping Specialty Services Afloat
April 3, 2020 – The math is clear to Pete Hamilton on how the 340B drug pricing program benefits underserved patients and the safety-net hospitals who care for them. As the pharmaceutical director for Genesis Healthcare System in southeastern Ohio, he provides some telling numbers when he discusses how his system is using the program for the community’s benefit. “Genesis … [Read more...]
340B Data Show How Savings Help Patients with Low Incomes and Protect Access in Rural Areas
April 2, 2020— Results from 340B Health’s annual survey of hospitals confirms the 340B drug pricing program is working the way Congress intended. Surveyed 340B hospitals report using their savings from prescription drug discounts to improve access to care and health outcomes for patients with low incomes and those living in rural communities. Hospital savings go to maintain or … [Read more...]
No Fooling: Drug Maker 340B Price Transparency Has Improved
April 1, 2020– The first of April is an opportunity for people to play good-natured pranks on their family and friends. But this year it also gives hospitals participating in the 340B drug pricing program a chance to reflect on something that is definitely not a joke – drug manufacturer pricing transparency has improved because of a federal website that went live a year ago … [Read more...]
340B Hospitals are Key to the COVID-19 Response
March 30, 2020 - As the nation battles the COVID-19 pandemic, 340B hospitals are playing a major role in providing care to all patients, especially those living with low incomes and those in rural communities that traditionally have been underserved. 340B hospitals are on the front lines of this response. Lawmakers in Washington recognize the importance of these hospitals … [Read more...]
Flawed Measures, Appearance of Bias in 340B Study
March 25, 2020 - A new research study published in Health Services Research finds hospitals newly enrolled in the 340B program provide more charity care, by offering more patients discounted care. Specifically, for newly enrolled 340B hospitals, the study finds: The amount of charity care provided increased by nearly 28.9 percent after 340B enrollment. The probability of … [Read more...]